Top Stories
-
Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Topic
-
Researchers Rebecca Kehm, PhD and Lauren Houghton, PhD, shed light on an emerging trend in early onset breast cancer, pointing to early adolescence as a key window that could provide needed answers.
Topic
-
A new advisory on how alcohol increases cancer risk addresses the growing body of evidence about alcohol’s harmful health impacts, including its direct link to cancer.
Topic
-
Join us in celebrating HICCC's top stories of the year.
Topic
Latest News
-
Source:
Columbia EngineeringMay 2, 2022Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.
- April 29, 2022
Expert geneticist Dr. Wendy Chung takes us through the ever-evolving genetics landscape and its revolutionary impact in cancer.
Topic
- April 27, 2022
Physician-scientists at the Herbert Irving Comprehensive Cancer Center are pioneering new tools--3D organoids--for treating head and neck cancer.
Topic
- April 19, 2022
Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
Topic
- April 14, 2022
In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.
Topic
-
Source:
CUIMC NewsroomApril 13, 2022A new instrument at Columbia will help scientists uncover the full potential of heavy ion radiation therapy and could improve treatment of pancreatic cancer and other difficult-to-treat tumors.
Topic
- March 22, 2022
Researchers have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells.
- March 2, 2022
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
Topic
- January 31, 2022
The Trainee Associate Member Pilot Grants Program aims to support up-and-coming graduate and medical student and post-graduate researchers across Columbia working on all aspects of cancer research.
Topic
- January 19, 2022
To stop acute myeloid leukemia, targeting neighboring bone cells may be a better strategy than directly targeting the cells that drive the cancer, suggests a new study led by Stavroula Kousteni, PhD.
Topic
